APA (7th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). (2006). Guidance for industry: Minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.

Chicago Style (17th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Minimally Manipulated, Unrelated, Allogeneic Placental/umbilical Cord Blood Intended for Hematopoietic Reconstitution in Patients with Hematological Malignancies. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2006.

MLA (9th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Minimally Manipulated, Unrelated, Allogeneic Placental/umbilical Cord Blood Intended for Hematopoietic Reconstitution in Patients with Hematological Malignancies. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2006.